Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)

Terminated

• Conditions: Patients With ECMO

• Registration Number: NCT03248596
• Lead Sponsor: Rennes University Hospital

Brief Summary

The aim of the study is a better understanding of hemorrhagic events causes in patients with ECMO, prevent them and decrease the number of transfusion.

Detailed Description

The most frequent complication during ECMO is hemorrhage especially as a curative anticoagulant treatment is necessary. The primary hemostasis is also affected with a von Willebrand disease and thrombopathy, well known but not studied by recent tests.The identification of primary haemostasis deficits with these tools would allow to supply them and decrease the morbi-mortality related to the transfusion.

Study Timeline

• Study Start: 2016-02
• Primary Completion: 2016-07
• Study Completion: 2016-07
• Study First Submitted: 2017-08-09
• Study First Submitted QC: 2017-08-09
• Study First Posted: 2017-08-14
• Status Verified: 2017-11
• Last Update Submitted: 2017-11-17
• Last Update Posted: 2017-11-21

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• Patient older than 18 years old
• Patient with ECMO
• Patient hospitalized in an intensive care unit at the University Hospital of Rennes

Exclusion Criteria

• Known history for constitutional pathology of the primary haemostasis
• Platelets < 100000 / mm3 or hematocrit < 28 % between H+12 and H+24

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate primary hemostasis in patient with ECMO at University Hospital of Rennes	Day 5

Trial Locations

Locations (1)

CHU de Rennes; 🇫🇷 Rennes, France